Alogliptin and Pioglitazone
- Product NDC
- 45802-304
- 11-digit product format
- 458020304
- Labeler code
- 45802
- Product ID
- 45802-304_35a2f49d-f0e8-4e6a-a9ae-a37484c0e7e7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Alogliptin Benzoate and Pioglitazone hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Application
- NDA022426
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2016-04-08
- Marketing end
- 0000-00-00
- Substance
- ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE
- Active strength
- 13 mg/1; mg/1
- Pharmacologic classes
- Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA], PPAR alpha [CS], PPAR gamma [CS], Peroxisome Proliferator Receptor alpha Agonist [EPC], Peroxisome Proliferator Receptor gamma Agonist [EPC], Peroxisome Proliferator-activated Receptor Activity [MoA], Thiazolidinedione [EPC], Thiazolidinediones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 45802-304-65 | 45802030465 | 30 TABLET, FILM COATED in 1 BOTTLE (45802-304-65) | 2016-04-08 | 0000-00-00 | No | No | Current |